| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.028 | 0.7 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.03 | 0.7 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |